Merck Foundation supports the First Public IVF and Fertility Center in Sub-Saharan Africa, established in Uganda
Merck Foundation commits to build cancer care capacity and support Uganda Cancer Institute as a Center of Excellence for East Africa
Merck Foundation underscored their commitment to long term partnership with Government of Uganda to build healthcare capacity with special focus on diabetes, cardiovascular diseases, infertility and cancer.During the high-level meeting between His Excellency Prime Minister of Uganda, Dr. Ruhakana Rugunda, Uganda Minister of State of Health, Hon. Sarah Opendi, Chairman of the Executive Board of E. Merck KG,
Prof. Frank Stangenberg-Haverkamp and the CEO of Merck Foundation Dr Rasha Kelej, Merck Foundation affirmed their commitment to long term partnership with the Government of Uganda to continue their efforts to improve access to healthcare solutions across the country which started in 2012.
Prof. Frank Stangenberg-Haverkamp, Chairman of Board of Trustees of Merck Foundation emphasized his commitment to working with Uganda Ministry of Health because of great strides the country has made in building regional centres of excellence for fertility and cancer.
“We appreciate the constant support from the Ministry of Health and thank the Government of Uganda in elevating the health status of Ugandans,” said Prof. Frank Stangenberg-Haverkamp.
Uganda Prime Minister, His Excellency Dr. Ruhakana Rugunda (third right) and Chairman of both Executive Board of E. Merck KG and Board of Trustees of Merck Foundation, Prof. Frank Stangenberg-Haverkamp (second right). Uganda Minister of State for Health Hon. Sarah Opendi (third left), Dr Rasha Kelej, CEO of Merck Foundation (second left) and other government officials during their meeting with Uganda Prime Minister.
Earlier, Merck Foundation together with Ministry of Health of Uganda held a series of meetings and visits to various health institutions and rural communities.
Merck Foundation together with the Uganda Ministry of Health visited rural villages in Western Uganda where ‘Merck More than a Mother’ campaign has established various income generating projects to support infertile women. The Merck Foundation handed over an oxen plough, poultry farms and table banking projects to ‘Merck More Than a Mother’ women groups to empower them socially and economically.
The ‘Merck More than a Mother’ women group in appreciation of the Foundation’s support gave Prof. Frank Stangenberg-Haverkamp and Dr Rasha Kelej turkeys from their flourishing poultry farm.
Prof. Frank Stangenberg Haverkamp Chairman of Merck Foundation Board of Trustees, Dr Rasha Kelej, CEO of Merck Foundation and Minister of State of Health Uganda, Hon. Sarah Opendi with ‘Merck More Than a Mother’ women groups opening the chicken farm in rural Uganda
“One of my most fulfilling moments is seeing these childless women lead happy and independent lives.It was very critical to partner with Ministry of health to enable us to reach to the heart of Africa and raise awareness about infertility prevention and management and break the stigma around infertile women. This is quite a transformation,” said Dr Rasha Kelej.
Merck Foundation, through their ‘Merck More than a Mother’ campaign focuses on empowering infertile women through access to information, awareness, health, change of mind set and economic support in addition to building fertility care capacity across the continent.
“Raising awareness about male infertility is very important to change the culture as the infertility affects women and men equally and yet women are the one who been solely blamed, discriminated and mistreated in their communities. The campaign will address this topic and encourage men to discuss openly their infertility and share the journey of infertility diagnosis and treatment with their wives,” Kelej added.
“Among the many projects we established for the childless women across Africa, it is the highlight of our work and efforts to travel here with the chairman of Executive Board of Merck KG, Prof. Frank Stangenberg-Haverkamp to the heart of Africa to help transform these women’s lives,” said Dr. Rasha Kelej, CEO of Merck Foundation.
Prof. Frank Stangenberg-Haverkamp, Minister of State of Health Hon. Sarah Opendi and Dr Rasha Kelej, CEO of Merck Foundation
During their visit to the new Women Maternal Hospital, Merck Foundation through the ‘Merck More than a Mother’ campaign committed to support the training of embryologists and fertility specialists and the establishment of the first public IVF centre in the new hospital which will be the first in sub-Saharan Africa as well. The First public IVF centre established in Kampala, Uganda aims to improve access to regulated and cost effective fertility care across Uganda and the rest of Africa.
Uganda State Minister of Health, Hon. Sarah Opendi (centre) with Prof. Frank Stangenberg-Haverkamp, Chairman of Executive board of E- Merck KG and Board of Trustees of Merck foundation (to her right) and Dr. Rasha Kelej, CEO of Merck Foundation during the tour of the New Women Maternal and Neonatal Hospital
During their visit to the Uganda Cancer Centre, Uganda Minister for Health, Hon. Sarah Opendi noted “cancer prevalence in Uganda is the highest in East Africa, with about 300 cases reported in every 1,000 people. She thanked the Merck Company for their continued support in healthcare in the country in terms of technological assistance and capacity building of oncologists and especially to the institute which is the only one of its kind in the region. “
And on his part, Chairman of the Board of Trustees of Merck Foundation, Prof Frank Stangenberg-Haverkamp, commended the high standards of Uganda Cancer Institute and their prudent use of funds in constructing and equipping the centre.
“Through Merck Cancer Access Program, Merck Foundation will continue doing what they do best, building cancer care capacity through providing one, two and three year oncology fellowship programs to doctors and technicians in partnership with the Ministry of Health of Uganda with the aim of increasing the limited number of oncologists in the country and across Africa” said Dr.Rasha Kelej.
Merck Foundation affirmed their support to the Cancer institute's role as a regional centre of excellence for East Africa.
left: Dr Nixon Niyozima of Uganda Cancer Institute explains a point to Chairman of the Executive Board of the Merck, Prof. Frank Stangenberg-Haverkamp, Uganda Minister of Health, Hon. Sarah Opendi, Dr Rasha Kelej, CEO of Merck Foundation and other officials when they toured the Uganda Cancer Institute.
Watch TV interviews of Merck Foundation CEO, Dr Rasha Kelej on the Merck More than a Mother campaign
Dr Rasha Kelej, CEO Merck Foundation; NTV-Uganda interview on the silent stigma of infertility
Watch more videos of how ‘Merck More than a Mother’ campaign has transformed women’s lives
Merck more than a Mother-The transformation of Ugandan infertile women
Watch what happened to Jackline Mwende, victim of infertility stigma, after meeting Merck Foundation
Watch videos of ‘Merck Africa Embryology Training Program’
Future embryologists of Nigeria
Future embryologists of Tanzania and Ghana
One Click on icon below to
Download Merck Foundation App
The Merck Foundation, established in 2017, is the philanthropic arm of Merck KGaA Germany, aims to improve the health and wellbeing of people and advance their lives through science and technology. Our efforts are primarily focused on improving access to quality & equitable healthcare solutions in underserved communities, building healthcare and scientific research capacity and empowering people in STEM (Science, Technology, Engineering, and Mathematics) with a special focus on women and youth. All Merck Foundation press releases are distributed by e-mail at the same time they become available on the Merck Foundation Website. Please visit www.merck-foundation.com to read more. To know more, reach out to our social media: Merck Foundation; Facebook, Twitter, Instagram, YouTube and Flicker.
Merck is a leading science and technology company in healthcare, life science and performance materials. Almost 52,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions.
Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma.